OraSure Technologies IncNASDAQ:OSUR
- LAST PRICE3.9300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.8800/ 6
- Ask / Lots4.3000/ 40
- Open / Previous Close--- / 3.9300
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OSUR |
|---|---|---|
| 09:32 ET | 11105 | 3.9 |
| 09:33 ET | 1050 | 3.92 |
| 09:39 ET | 100 | 3.94 |
| 09:42 ET | 1460 | 3.94 |
| 09:44 ET | 6700 | 3.94 |
| 09:48 ET | 1700 | 3.97 |
| 09:50 ET | 2400 | 3.965 |
| 09:51 ET | 2554 | 3.945 |
| 09:53 ET | 1490 | 3.94 |
| 09:57 ET | 2000 | 3.92 |
| 10:00 ET | 200 | 3.925 |
| 10:02 ET | 300 | 3.91 |
| 10:04 ET | 9805 | 3.935 |
| 10:06 ET | 1485 | 3.94 |
| 10:08 ET | 200 | 3.935 |
| 10:09 ET | 100 | 3.935 |
| 10:11 ET | 200 | 3.935 |
| 10:13 ET | 400 | 3.935 |
| 10:15 ET | 600 | 3.935 |
| 10:18 ET | 6244 | 3.94 |
| 10:20 ET | 4380 | 3.925 |
| 10:22 ET | 36101 | 3.944 |
| 10:24 ET | 1966 | 3.94 |
| 10:26 ET | 23475 | 3.955 |
| 10:27 ET | 15949 | 3.96 |
| 10:29 ET | 925 | 3.98 |
| 10:31 ET | 15554 | 3.965 |
| 10:33 ET | 15283 | 3.995 |
| 10:36 ET | 15705 | 3.995 |
| 10:38 ET | 3517 | 3.985 |
| 10:40 ET | 1592 | 4.005 |
| 10:42 ET | 3100 | 4.005 |
| 10:44 ET | 202 | 4.01 |
| 10:45 ET | 14358 | 4.0101 |
| 10:47 ET | 8400 | 4.0108 |
| 10:49 ET | 5260 | 4 |
| 10:51 ET | 1000 | 4.01 |
| 10:54 ET | 4824 | 4.005 |
| 10:58 ET | 3302 | 4.005 |
| 11:00 ET | 150 | 4.0089 |
| 11:02 ET | 108 | 4 |
| 11:03 ET | 100 | 4 |
| 11:05 ET | 100 | 4.005 |
| 11:09 ET | 200 | 4 |
| 11:12 ET | 11200 | 4.01 |
| 11:14 ET | 2243 | 3.995 |
| 11:16 ET | 2022 | 3.985 |
| 11:18 ET | 1500 | 3.985 |
| 11:20 ET | 2094 | 3.985 |
| 11:21 ET | 4000 | 3.985 |
| 11:23 ET | 2628 | 3.975 |
| 11:25 ET | 2058 | 3.97 |
| 11:27 ET | 8000 | 3.97 |
| 11:30 ET | 5586 | 3.965 |
| 11:32 ET | 5460 | 3.985 |
| 11:34 ET | 1720 | 3.995 |
| 11:36 ET | 4525 | 3.98 |
| 11:38 ET | 1117 | 3.975 |
| 11:39 ET | 200 | 3.975 |
| 11:41 ET | 316 | 3.9788 |
| 11:43 ET | 18151 | 3.97 |
| 11:45 ET | 2019 | 3.9601 |
| 11:48 ET | 100 | 3.96 |
| 11:50 ET | 2300 | 3.96 |
| 11:54 ET | 300 | 3.96 |
| 11:57 ET | 5400 | 3.955 |
| 11:59 ET | 4023 | 3.96 |
| 12:01 ET | 300 | 3.955 |
| 12:03 ET | 5200 | 3.955 |
| 12:06 ET | 3413 | 3.96 |
| 12:08 ET | 621 | 3.95 |
| 12:12 ET | 3900 | 3.95 |
| 12:14 ET | 100 | 3.955 |
| 12:15 ET | 427 | 3.95 |
| 12:19 ET | 1500 | 3.95 |
| 12:21 ET | 100 | 3.945 |
| 12:24 ET | 200 | 3.94 |
| 12:26 ET | 3800 | 3.93 |
| 12:28 ET | 200 | 3.93 |
| 12:30 ET | 789 | 3.93 |
| 12:32 ET | 10638 | 3.935 |
| 12:35 ET | 9057 | 3.925 |
| 12:37 ET | 4181 | 3.94 |
| 12:39 ET | 204 | 3.9312 |
| 12:42 ET | 800 | 3.935 |
| 12:44 ET | 420 | 3.9364 |
| 12:46 ET | 200 | 3.93 |
| 12:48 ET | 8446 | 3.925 |
| 12:50 ET | 5212 | 3.93 |
| 12:51 ET | 7122 | 3.93 |
| 12:55 ET | 7075 | 3.93 |
| 01:00 ET | 5389 | 3.935 |
| 01:02 ET | 1300 | 3.95 |
| 01:04 ET | 400 | 3.96 |
| 01:06 ET | 4229 | 3.955 |
| 01:08 ET | 2189 | 3.95 |
| 01:09 ET | 1458 | 3.94 |
| 01:11 ET | 100 | 3.94 |
| 01:13 ET | 200 | 3.94 |
| 01:15 ET | 7006 | 3.935 |
| 01:18 ET | 14831 | 3.94 |
| 01:20 ET | 956 | 3.935 |
| 01:22 ET | 2842 | 3.955 |
| 01:29 ET | 383 | 3.9501 |
| 01:31 ET | 7863 | 3.955 |
| 01:38 ET | 200 | 3.955 |
| 01:40 ET | 13829 | 3.97 |
| 01:42 ET | 6549 | 3.965 |
| 01:45 ET | 5700 | 3.98 |
| 01:49 ET | 14542 | 3.975 |
| 01:51 ET | 100 | 3.98 |
| 01:58 ET | 200 | 3.975 |
| 02:00 ET | 250 | 3.98 |
| 02:03 ET | 9950 | 3.975 |
| 02:05 ET | 200 | 3.98 |
| 02:09 ET | 2600 | 3.975 |
| 02:12 ET | 1815 | 3.98 |
| 02:14 ET | 1290 | 3.98 |
| 02:16 ET | 1953 | 3.98 |
| 02:18 ET | 200 | 3.975 |
| 02:20 ET | 500 | 3.98 |
| 02:23 ET | 300 | 3.975 |
| 02:25 ET | 1800 | 3.965 |
| 02:27 ET | 592 | 3.965 |
| 02:30 ET | 100 | 3.96 |
| 02:32 ET | 200 | 3.96 |
| 02:34 ET | 100 | 3.965 |
| 02:36 ET | 100 | 3.965 |
| 02:38 ET | 200 | 3.96 |
| 02:39 ET | 1559 | 3.96 |
| 02:41 ET | 200 | 3.96 |
| 02:43 ET | 900 | 3.965 |
| 02:45 ET | 397 | 3.965 |
| 02:48 ET | 600 | 3.965 |
| 02:50 ET | 300 | 3.965 |
| 02:54 ET | 1250 | 3.96 |
| 02:56 ET | 100 | 3.96 |
| 02:57 ET | 254 | 3.965 |
| 02:59 ET | 200 | 3.965 |
| 03:01 ET | 500 | 3.97 |
| 03:03 ET | 595 | 3.965 |
| 03:06 ET | 3162 | 3.955 |
| 03:08 ET | 6845 | 3.96 |
| 03:10 ET | 2390 | 3.9673 |
| 03:12 ET | 1521 | 3.965 |
| 03:15 ET | 780 | 3.965 |
| 03:17 ET | 300 | 3.97 |
| 03:19 ET | 300 | 3.965 |
| 03:21 ET | 3130 | 3.955 |
| 03:24 ET | 584 | 3.951 |
| 03:26 ET | 400 | 3.95 |
| 03:28 ET | 300 | 3.95 |
| 03:30 ET | 609 | 3.95 |
| 03:32 ET | 300 | 3.955 |
| 03:33 ET | 1400 | 3.955 |
| 03:35 ET | 200 | 3.955 |
| 03:37 ET | 300 | 3.955 |
| 03:39 ET | 100 | 3.955 |
| 03:42 ET | 4671 | 3.95 |
| 03:44 ET | 11022 | 3.945 |
| 03:46 ET | 3200 | 3.93 |
| 03:48 ET | 10867 | 3.935 |
| 03:50 ET | 5590 | 3.93 |
| 03:51 ET | 7823 | 3.93 |
| 03:53 ET | 5551 | 3.935 |
| 03:55 ET | 6800 | 3.935 |
| 03:57 ET | 4887 | 3.93 |
| 04:00 ET | 108747 | 3.93 |
Nov 18, 2024
OraSure to Participate in Upcoming Investor Conference, from 4:05PM ET on Monday Nov 18, 2024 by Dow Jones
4:05PM ET on Monday Nov 18, 2024 by Dow Jones
Nov 6, 2024
*DJ OraSure 3Q Loss/Shr 6c >OSUR, from 4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones
4:05PM ET on Wednesday Nov 06, 2024 by Dow JonesOraSure Reports Q3 '24 Revenue of $39.9 Million, from 4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones
4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
OraSure Technologies Inc | 289.4M | 26.1x | +75.98% |
AngioDynamics Inc | 277.5M | -1.2x | --- |
Nevro Corp | 169.4M | -2.4x | --- |
ZimVie Inc | 391.1M | -8.1x | --- |
Inogen Inc | 223.4M | -4.3x | --- |
Cerus Corp | 332.4M | -16.9x | --- |
Company Information
OraSure Technologies, Inc. provides point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Its business also includes molecular sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
Contact Information
- Headquarters
- 220 E First StBETHLEHEM, PA, United States 18015
- Phone
- 503-641-6115
- Fax
- 610-882-1830
Executives
- Independent Chairman of the Board
- Mara Aspinall
- President, Chief Executive Officer, Director
- Carrie Eglinton Manner
- Chief Financial Officer
- Kenneth Mcgrath
- Chief Product Officer
- Kathleen Weber
- Independent Director
- James Datin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $289.4M |
|---|---|
Revenue (TTM) | $224.3M |
Shares Outstanding | 74.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.04 |
EPS | $0.15 |
Book Value | $5.86 |
P/E Ratio | 26.1x |
Price/Sales (TTM) | 1.3 |
Price/Cash Flow (TTM) | 11.8x |
Operating Margin | -5.32% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
